APA (7th ed.) Citation

Sarkar, S., Kumari, D., Gupta, S. K., Sharma, V., Mukhi, S., Kamboj, P., . . . Dikshit, M. (2021). Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Elsevier.

Chicago Style (17th ed.) Citation

Sarkar, Soumalya, et al. Saroglitazar and Hepano Treatment Offers Protection Against High Fat High Fructose Diet Induced Obesity, Insulin Resistance and Steatosis by Modulating Various Class of Hepatic and Circulating Lipids. Elsevier, 2021.

MLA (8th ed.) Citation

Sarkar, Soumalya, et al. Saroglitazar and Hepano Treatment Offers Protection Against High Fat High Fructose Diet Induced Obesity, Insulin Resistance and Steatosis by Modulating Various Class of Hepatic and Circulating Lipids. Elsevier, 2021.